ClinicalTrials.Veeva

Menu
T

The Headache Center | Headache Neurology Research Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Atogepant
Eptinezumab
quinidine
Dextromethorphan
Ubrogepant
AMG334

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 16 total trials

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) (UBRO PEDS OLE)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant

Trial sponsors

Allergan logo
Theranica logo
AbbVie logo
Lundbeck logo
Amgen logo
E
Mayo Clinic logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems